High-affinity 3H-imipramine Binding in Platelets from Untreated and Treated Depressed Patients Compared to Healthy Volunteers
Overview
Authors
Affiliations
Specific high-affinity binding of 3H-imipramine to human platelets possesses very similar characteristics to the sites previously described in animal and human brains. In a study comparing the binding of 3H-imipramine in platelets obtained from 39 control volunteers with 37 hospitalized, untreated, severely depressed patients, the maximal binding of 3H-imipramine was found to be significantly lower in the depressed population. There were no differences in the KD values. After 7-15 days of treatment with tricyclic anti-depressant drugs, there was an improvement in the degree of the depression but no significant change in the maximal 3H-imipramine binding. After an average of 50 days treatment, Hamilton ratings had returned to normal, but the 3H-imipramine binding values remained unchanged.
Ward M, Irazoqui P Front Neuroeng. 2010; 3:7.
PMID: 20631824 PMC: 2901135. DOI: 10.3389/fneng.2010.00007.
Specific 3H-imipramine binding in human platelets. Influence of age and sex.
Langer S, Briley M, Raisman R, Henry J, Morselli P Naunyn Schmiedebergs Arch Pharmacol. 1980; 313(3):189-94.
PMID: 7432551 DOI: 10.1007/BF00505732.
Raisman R, Briley M, Bouchami F, Sechter D, Zarifian E, Langer S Psychopharmacology (Berl). 1982; 77(4):332-5.
PMID: 6813892 DOI: 10.1007/BF00432765.
3H-Rauwolscine binding in platelets from depressed patients and healthy volunteers.
Pimoule C, Briley M, Gay C, Loo H, Sechter D, Zarifian E Psychopharmacology (Berl). 1983; 79(4):308-12.
PMID: 6407043 DOI: 10.1007/BF00433407.
Poirier M, Galzin A, Pimoule C, Schoemaker H, Le Quan Bui K, Meyer P Psychopharmacology (Berl). 1988; 94(4):521-6.
PMID: 3131797 DOI: 10.1007/BF00212848.